AstraZeneca, a global leader in the pharmaceutical industry, has appointed Preeti Chhatbar as the new Director of International Biopharma Communications. In her new role, Chhatbar will spearhead strategic communications across key regions, including Asia Pacific, Latin America, the Middle East, and Africa. Her leadership will focus on AstraZeneca's critical therapy areas: Cardiovascular, Renal & Metabolism (CVRM), Respiratory & Immunology (R&I), and Vaccines & Immune Therapies (V&I).With over 20 years of experience in healthcare communications, Preeti Chhatbar brings a wealth of knowledge and expertise to her new position. She has held several senior roles in global pharmaceutical companies, where she successfully managed complex communications strategies, particularly in emerging markets. Her strategic insights are expected to enhance AstraZeneca?ÇÖs visibility and engagement across the diverse and rapidly evolving biopharma landscape.AstraZeneca?ÇÖs recent advancements in these therapy areas have been significant. The company's CVRM portfolio has seen substantial growth, with leading products such as Farxiga (dapagliflozin) gaining approvals for heart failure and chronic kidney disease treatments. In the Respiratory & Immunology space, AstraZeneca continues to make strides with biologics like Fasenra (benralizumab), which has shown promise in treating severe asthma. The Vaccines & Immune Therapies unit remains a focal point, particularly after the global success of AstraZeneca's COVID-19 vaccine, Vaxzevria, which has been a key player in the global pandemic response.Chhatbar?ÇÖs appointment comes at a pivotal time for AstraZeneca as the company continues to strengthen its position in global markets, particularly in regions where the demand for innovative biopharmaceutical solutions is rapidly increasing. Her role will be crucial in shaping the narrative and communication strategies that support AstraZeneca?ÇÖs mission to transform the lives of patients through science and innovation.In her capacity as Director, Chhatbar will also work closely with regional teams to align AstraZeneca?ÇÖs communications strategies with local healthcare priorities, ensuring that the company?ÇÖs messaging resonates with stakeholders across different cultural and regulatory environments. Her leadership is expected to drive impactful communication efforts that support AstraZeneca?ÇÖs growth and reinforce its commitment to addressing unmet medical needs worldwide.